Emerging Regional Markets
25-Aug-2011 | News-Press Release
Bharatbook added a new report on "Emerging Regional Markets for Therapeutic Drugs" which gives the in-depth analysis and forecast on Emerging Regional Markets for Therapeutic Drugs
An overview of emerging markets for therapeutic drugs in the following countries and regions: China, Eastern Europe, India, Latin America, Middle East, Russia, South Africa, South Korea, and Turkey. Includes forecasts through 2015
The overall emerging markets for therapeutic drugs totaled $131.4 billion in 2009. These regions include Latin America, China, Eastern Europe, the Middle East, South Korea, India, Russia, and South Africa.
These regions are estimated at $145.8 billion in 2010 and expected to continue aggressive growth through 2015, reaching a figure of $214.2 billion, yielding a compound annual growth rate (CAGR) of 8% from 2010 to 2015.
The Eastern European market is estimated at $32.2 billion in 2010, an increase of 13.4% from 2009. A sharp increase is expected in the next 5 years, reaching a value of $55 billion by 2015, a compound annual growth rate (CAGR) of 11.5%.
Russia is a large market, given its single country position—this $6.5 billion market in 2009 hit $7.4 billion as of 2010 and is projected to reach $10.5 billion by 2015, a 2010 to 2015 compound annual growth rate (CAGR) of 7.1%.
STUDY GOALS AND OBJECTIVES
This study provides a comprehensive analysis of emerging geographic markets on a global basis. Its aim is to provide a range of information, from detailed company analyses within disease subsegments to overall industry trends, in order to quantify and qualify the market for therapeutic drug products in the emerging geographic markets. Forecasts and trends are developed from a cross-reference of data points, gleaned from proprietary industry sources, company publications, industry benchmarking, and other divergent data sources to arrive at a cogent and coordinated forecast.(http://www.bharatbook.com/detail.asp?id=168821&rt=Emerging-Regional-Markets-for-Therapeutic-Drugs.html )
SCOPE OF REPORT
Current and projected product forecasts during the forecast period (2010–2015) are discussed. As well, new products approved in 2009 and 2010 by the U.S. Food and Drug Administration (FDA), and those products expected to be approved within the forecast period, are projected. The figure for 2010 is estimated, except where actual results have been reported, due to the release timing of the report.
The report includes analysis of leading and emerging competitors in current worldwide emerging geographic markets. Profiles of manufacturers of leading products as well as biotechnology companies with novel products in development are analyzed to define their specific product strategies employed. This report also assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment. The competitive environment is examined with a special focus on how new products and technologies are influencing the current standard of care. Detailed profiles of current market leaders are discussed, as well as companies with innovative products poised to advance within the forecast period.
Market figures are based on revenues at the manufacturers’ level and are projected at 2010 dollar value. Inflation is not computed into the projection figures. Trends are assessed based on projected sales for existing products, new product introductions, expanded indications for existing products, and projected changes in the prevalence, diagnosis, and scripting rates for certain diseases.
Included in this report are forecasts by product, product category, and by company from 2009 through 2015. The study is arranged to offer an overview of the emerging geographic markets accompanied by product, company, geography, and mechanism of action with forecasts broken down and covered by geographic region or country. Virtually every emerging geographic region across the entire globe is covered.
Excluded from this report are over-the-counter (OTC) medications, and other consumables that do not require a physician’s prescription.
Sales figures are reported in U.S. dollars and in each case reflect currency fluctuations within the performance of revenue change. Revenue figures do not account for variation in local currencies.
All market share data is on a global basis, unless specifically noted.
This release was submitted by a PRSafe user.
Any communication related to the content of this release should be sent to the release submitter.
- Demand ForecastMarketMarket ForecastMarket GrowthMarket LeadersMarket ShareMarket SizeResearchDrugsMarket ReportReportTherapy / Therapeutics
- Research on Global and China Epoxy Resin Industry Chain Report
- The Geothermal Energy Market 2012-2022
- Adhesives and Sealants: Global Markets
- Dermatological Drugs: World Market Prospects 2012-2022
- The Electric and Range Extended Electric Light-Vehicle Report
- India Urban & Industrial Waste to Energy Market
- Understanding Russia's Regional Health Markets
- 2012 Deep Research Report on China Wind Bearing Industry
- Top 1000 Advertising Agents (European)
- HNWI Asset Allocation in Switzerland to 2016